Nanobody Based Imaging and Targeting of ECM in Disease and Development
Methods for developing disease-related nanobodies and related products and kits are provided. The disease- specific proteins are extracellular matrix (ECM) proteins, domains or epitopes that are associated with various aspects of disease and are not present, or are present in very low quantities, in non-diseased individuals. Highly effective nanobodies capable of specifically binding to these ECM protein epitopes useful in in vivo imaging assays, the detection, diagnosis and treatment of diseases as well as monitoring therapeutic progress in a patient with a disease are provided herein.
Researchers
-
nanobody based imaging and targeting of ecm in disease and development
Japan | Granted | 7,644,441 -
nanobody based imaging and targeting of ecm in disease and development
United States of America | Granted | 11,597,769 -
nanobody based imaging and targeting of ecm in disease and development
United States of America | Published application -
nanobody based imaging and targeting of ecm in disease and development
Japan | Published application -
nanobody based imaging and targeting of ecm in disease and development
China | Published application -
nanobody based imaging and targeting of ecm in disease and development
European Patent Convention | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.